TrialThe Lancet. Infectious diseases2011

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Glenda E Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.